CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Autosomal Dominant Polycystic Kidney Disease (ADPKD) is the most common genetic cause of kidney disease that caus...
Phase 2
Rome, Roma, Italy and 92 other locations
with placebo in participants with atherosclerotic cardiovascular disease (ASCVD) and/or chronic kidney disease (CKD). Part...
Phase 3
Roma, Italy and 560 other locations
This is a Phase III, randomized, double-blind, parallel-group, placebo-controlled multicenter study to investigate outcomes with elecoglipron compare...
Phase 3
Rome, Italy and 425 other locations
to evaluate efficacy, safety and tolerability of treatment with zibotentan/dapagliflozin and dapagliflozin alone in participants with chronic kidney...
Phase 3
Roma, Italy and 297 other locations
This study is open to children aged 2 to 17 with chronic kidney disease (CKD). The purpose of this study is to find out if a medici...
Phase 3
Roma, Italy and 98 other locations
and Tolerability of Baxdrostat in combination with Dapagliflozin on renal outcomes and cardiovascular mortality in participants with chronic kidney...
Phase 3
Roma, Italy and 757 other locations
of serious heart-related complications or prevent the worsening of kidney function. The trial will enroll adults with body mass index 27 kg/ ...
Phase 3
Roma, Italy and 762 other locations
disease (ASCVD) or diabetes with end stage kidney disease (ESKD) undergoing maintenance dialysis....
Phase 2, Phase 3
Rome, Italy and 555 other locations
This study is open to adults with chronic kidney disease at risk of progression. People with and without type 2 diabetes can take p...
Phase 3
Roma, Italy and 516 other locations
AFFINITY Study is a phase 2, open-label, basket study to evaluate the efficacy and safety of atrasentan in patients with proteinuric glomerular disease...
Phase 2
Roma, RM, Italy and 38 other locations
Clinical trials
Research sites
Resources
Legal